Not exact matches
«Cancer cells disguise themselves by switching off
genes, new research reveals: A genome - wide
map of the
genes switched off in aggressive
tumors reveals a «signature».»
In a study published in Neoplasia, researchers at the Washington University School of Medicine created a
map showing which
genes were switched on and off in different parts of the
tumor, providing a «signature» of these switches throughout the genome.
In this special section of Science, expert contributors retrace the long and tortuous path leading to the
mapping and identification of the BRCA1
gene; discuss the ways in which BRCA mutation status has been integrated into the clinical management of patients in high - risk families; and highlight the role of the BRCA proteins in preserving the structural and numerical integrity of chromosomes throughout the cell cycle, a function that may explain their
tumor suppressor activity.
Based on how the
genes fit within the original,
mapped profile, they can predict with a high accuracy if a particular patient will develop metastatic
tumors.
In four
tumors, the vector
mapped to a section of chromosome 12 and turned on several
genes implicated in cancer, the team reports tomorrow in Science.
The resulting «
map» of
gene - drug interactions allowed the researchers to accurately predict the responses of multiple human cancer cell lines to different chemotherapy agents based on the cell lines» genetic profiles and also revealed new genetic factors that appear to determine the response of breast and ovarian
tumor cells to common classes of chemotherapy treatment.
That genetic
map led to key insights, such as the link between glioblastoma, the deadliest type of brain
tumor, and a
gene called BEX1.
Interestingly, the most commonly mutated set of
genes were those involved in epigenetic modification (25 % of
tumors) followed by transcriptional regulators and
MAP kinase - associated
genes (12 - 15 %).